On 22 May 2025, at the 10th Anniversary Gala of the China–Australia Free Trade Agreement (ChAFTA) held at NSW Parliament House, Homart Group was honoured with the prestigious “Best Achievement of CIIE” award. This accolade recognises companies that have made outstanding contributions to bilateral trade between China and Australia. It also marks Homart’s 26th international award, reaffirming the company’s global influence and long-term commitment to the health and wellness industry.

As a key player in Australia’s health sector, Homart has participated in the China International Import Expo (CIIE) six times since its inaugural edition in 2018. At the 7th CIIE in 2024, Homart’s booth attracted more than 100,000 visitors, drawing attention from industry leaders, media, and government representatives. The brand was also featured in CCTV’s “Made in Power” program, highlighting its role as a standout example of Australian manufacturing.

Presented during Australian Made Week (19–25 May), the award underscores the important role Australian-made brands play in building global trade partnerships and consumer trust. Today, Homart owns and operates 14 premium Australian brands, including SpringLeaf, Thompson’s, Thursday Plantation, AUTILI, PETMIMA, Toplife, CHERI, and Grandpawpaw — spanning health supplements, skincare, infant nutrition, and pet care.

Since its founding in 1992, Homart has remained committed to its mission: “Made in Australia, Healthy the World.” The Group has achieved consistent year-on-year profitability and reported double growth in both revenue and profit in FY2025. Homart is now actively preparing for its listing on the main board of the Australian Securities Exchange (ASX), entering a new phase of global expansion. In China, the Group operates over 30 flagship stores across major cross-border e-commerce platforms, with products widely available in pharmacy chains, maternity stores, and online channels. Many of its products have received “Blue Hat” certification for large-scale health product importation, as well as certifications for pet supplements.

Earlier that day, during the ChAFTA forum, Homart CEO and Founder Ms. Lynn Yeh delivered a keynote address and joined discussions with business and government leaders — including the CEO of Australian Made and former Australian Trade Ministers — on topics such as brand internationalisation, Australia’s manufacturing advantages, and the future of bilateral cooperation. As a long-standing CIIE exhibitor, Homart was recognised as a crucial bridge between the Australian and Chinese health industries.

Looking Ahead

This recognition is not only a celebration of Homart’s achievements in the Chinese market — it’s also a strong affirmation of the Group’s commitment to innovation, product excellence, and cross-border collaboration.

Moving forward, Homart will continue to drive global growth through innovation, quality, and strategic partnerships — delivering trusted Australian health solutions to the world.

The post Homart Group Wins “Best Achievement of CIIE” Award at the 10th Anniversary of ChAFTA appeared first on Homart Pharmaceuticals.

This event was hosted by both China International Import Expo Bureau and the National Convention & Exhibition Center (Shanghai), and supported by the Australian-Chinese Embassy and gathered more than 100 enterprises and business associations with official presence from the Chinese Consulate General in Sydney, the Australian China General Chamber of Commerce, as well as the N.S.W government.
 

 
Homart’s Group CEO, Lynn Yeh, and General Manager, Ross Norris Homart Group, signed the agreement together with the Head of the Exhibition Department of CIIE bureau. Homart continues to support CIIE 2020 as the representative of an outstanding Australian designed and Australian-made company.

Homart Group was founded in 1992. It has its own cGMP pharmaceutical factory in Australia, its own brands “Spring Leaf”, “TOP LIFE”, “CHERI”, ” Grandpawpaw”, “AUTILI”, and “Health N Nature” are high-quality, modern, 100% Australian-produced health foods, skin care and dairy products. At the 2008 Beijing Olympics, the 2010 Shanghai World Expo and the 2016 Hangzhou G20 Summit, Homart is the only health product supplier in the Australian Pavilion, and has won 16 international awards in Australia for 6 consecutive years. It is also designated by Australian Olympic athletes and Miss Universe Australia. It is a Healthy food brand and product quality is preference. Australian first choice in health care, Homart!

The post Homart become one of the first companies to sign up with the CIIE for 2020 appeared first on Homart Pharmaceuticals.

Homart was honoured be part of this successful journey and hosted our own double-sized booth at Main Hall 7.2, Skin care & beauty in Hall 6.1. We also partnered up with Australia Post at their pavilion booth in Hall 5.1. to support the Aussie spirit.

Honourable Guest, Deputy Premier John Barilaro from the N.S.W Australia, paid a special visit to our booth to commemorate his gratitude for Homart as a proud Australian-made company.

During this Expo, Lynn Yeh, CEO of Homart Group was an honourable guest speaker at the “China (Nanjing) Cross-border e-Commerce Import Commodity Procurement Fair” themed as “New Opportunities, New Economy, New Format and New Consumption” for sharing of best practices with the audience.

The event brought Homart huge success in closing some contracts with some small, medium and large enterprises.

Homart Group was founded in 1992. It has its own cGMP pharmaceutical factory in Australia, its own brands “Spring Leaf”, “TOP LIFE”, “CHERI”, ” Grandpawpaw”, “AUTILI”, and “Health N Nature” are high-quality, modern, 100% Australian-produced health foods, skin care and dairy products. At the 2008 Beijing Olympics, the 2010 Shanghai World Expo and the 2016 Hangzhou G20 Summit, Homart is the only health product supplier in the Australian Pavilion, and has won 16 international awards in Australia for 6 consecutive years. Australian first choice in health care, Homart!

The post CIIE – another successful journey for Homart appeared first on Homart Pharmaceuticals.